Virbagen Omega Two Dose Pack
Vetoquinol |
VOMEG002

Virbagen Omega Two Dose Pack

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Virbagen® Omega contains recombinant interferon omega of feline origin. Type I interferons are cytokines that act as protein messengers which induce multiple immune pathways in the cell. These include the increased production of potent anti-viral proteins and enzymes. Licensed to treat Canine Parvovirus, Virbagen® Omega is administered intravenously and is proven to decrease mortality rate when used in conjunction with supportive therapies.
  • Licensed for the treatment of parvovirus in dogs
  • Mortality in dogs is reduced by 4.4x when using Virbagen® Omega in combination with supportive therapy rather than supportive therapy alone.
  • When looking specifically at an unvaccinated population, the use of Virbagen® Omega decreases mortality by 6.4 times
  • Reduces clinical signs of parvovirus to facilitate a quicker recovery
  • The canine dose 2.5 MU/Kg IV once daily for 3 days.Use in a 10kg dog would require 25MU per day and therefore 75MU for the course. One vial of reconstituted Virbagen® Omega contains 10MU of interferon,which would result in 2.5 vials per day for this example
  • Licensed, also, to treat FeLV and FIV/FeLV co-infected cats where it is proven to:
    • Significantly reduce the clinical signs
    • Decrease overall mortality rate
    • Improve overall quality of life
  • In cats, Virbagen® Omega should be injected subcutaneously once daily for five consecutive days, at a dose rate of 1 MU/kg bodyweight, starting on days 0, 14 and 60.
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4